# Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）

> **NCT05745259** · PHASE3 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 1630 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Alteplase
- **DRUG:** Tenecteplase

## Key facts

- **NCT ID:** NCT05745259
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-26
- **Primary completion:** 2023-11-04
- **Final completion:** 2024-03-29
- **Target enrollment:** 1630 (ESTIMATED)
- **Last updated:** 2023-02-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05745259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05745259, "Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05745259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*